| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |